February marks another American Heart Month: a time to reflect on our cardiovascular health. This is the 57th year the federally designated event has been commemorated, but this year it holds...
Adverse Drug Events (ADEs) are potentially very dangerous to patients and are amongst the top causes of morbidity and mortality. Monitoring & reporting of ADEs is required by pharma companies...
Earlier this month, it was reported that the Centers for Disease Control and Prevention (CDC) instructed states to sign data use agreements that commit them for the first time to sharing personal...
If 2020 has taught us anything, it’s that the need for faster development, testing, and regulatory approval for new medical treatments is critical to public health. With the acceleration of...